MedTrace Logo

Oral Lactoferrin Versus Iron Supplementation During Pregnancy

NCT03542825 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-12-28

No results posted yet for this study

Summary

Iron deficiency anemia (IDA) is the condition in which there is anemia due to a lack of iron. The oral route is preferred to the parenteral route to replace iron stores \[Sharma JB; et al., 2004\]. Inorganic iron has poor bio-availability in addition to many side effects, including gastrointestinal discomfort, nausea, vomiting, diarrhea and constipation and it may sometimes increase susceptibility to infection \[ So¨lvell L; et al., 1970\].

Conditions

  • Iron-deficiency

Interventions

DRUG

Lactoferrin

parallel use of the three drugs to compare the efficacy of each arm in prevention of anemia

DRUG

Iron Supplement

Iron Sulphate 150 mg once daily

DRUG

Chelates, Iron

Amino acid chelated iron capsules contain 15 mg

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • Mohammad AM Ahmed, MD · South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department, Qena, Qena, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-09-01
Completion
2018-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03542825 on ClinicalTrials.gov